Skip to main content
PolicySpeak
← All files
IG

innoVance GmbH

Company · Germany

not in the EU Transparency RegisterThis organization files on consultations without a register number, so its record here is built from its filings alone. Register facts (staff, costs, accreditations) are not available for it.

2
positions filed
in the 665 files tracked
1
legislative file
of 665 tracked
0
with a full position paper
attached to a submission

Counts here are a floor, never a total: they cover the 665 consultation files tracked so far (57,800 submissions, mostly 2021–26), so an organization's real filing history is larger, not smaller.

Track innoVance in PolicySpeak: request access →

Follow innoVance GmbH

An email when this organization files on a consultation we publish.

We use your email for these updates, and PolicySpeak may contact you about the product. Unsubscribe in one click. Privacy policy.

Work at innoVance GmbH? so we know who speaks for it.

Their record over time

innoVance GmbH filed 2 positions between 27 Apr 2026 and 5 May 2026, across 1 of the 665 legislative files tracked here.

What they argued

Simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and support of the European Medicines Agency for the expert panels on medical devices and the list of Union harmonisation legislationfiled 5 May 2026source

As a service provider for innovation-supporting measures under the Medical Technology Programme of the German Federal Ministry of Research, Technology & Space (BMFTR), we highly welcome the COM proposal to reform MDR and IVDR. Generating clinical evidence through clinical investigations for medical devices is key, but costly.

Simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and support of the European Medicines Agency for the expert panels on medical devices and the list of Union harmonisation legislationfiled 27 Apr 2026source

Art. 82 MDR Handling of other clinical investigations As a service provider for innovation-supporting measures under the Medical Technology Programme of the German Federal Ministry of Research, Technology and Space (BMFTR), we welcome the COM proposal to reform the MDR and IVDR. The Commission proposes the complete removal of Article 82 MDR on other clinical investigations.

Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.

Put innoVance GmbH next to another organization. Same files, same register facts, side by side. Compare →

Is this your organization?

Everything on this page comes from innoVance GmbH’s own submissions to the European Commission. We have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.

Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.